abrdn Investment Management’s Edwards Lifesciences EW Stock Holding History

abrdn Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-26,388	Closed	-$560K	–	277
2014 Q4	$560K	Sell	26,388 -276	-1%	-$5.54K	﹤0.01%	318
2014 Q3	$454K	Sell	26,664 -132	-0.5%	-$2.08K	﹤0.01%	438
2014 Q2	$383K	Buy	+26,796	New	+$363K	﹤0.01%	472
2014 Q1	–	Sell	-28,926	Closed	-$317K	–	491
2013 Q4	$317K	Sell	28,926 -6	-0%	-$68	﹤0.01%	457
2013 Q3	$336K	Buy	+28,932	New	+$338K	﹤0.01%	454

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

abrdn Investment Management's EW Position: Q1 2015 in Review

abrdn Investment Management sold out of Edwards Lifesciences (EW) in Q1 2015, closing a stake of 26,388 shares — an estimated $560K sold.

abrdn Investment Management first reported a position in EW in Q3 2013 and held it in 5 quarters. The position peaked at $560K in Q4 2014. 576 funds tracked by Wall St. Rank hold EW as of Q1 2015.

abrdn Investment Management reported no remaining Edwards Lifesciences position as of Q1 2015 after selling out during the quarter.
abrdn Investment Management sold 26,388 Edwards Lifesciences shares in Q1 2015, an estimated $560K.
abrdn Investment Management first reported a position in Edwards Lifesciences in Q3 2013 and held it in 5 quarters.
abrdn Investment Management's Edwards Lifesciences position peaked at $560K in Q4 2014.
576 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2015.

Based on abrdn Investment Management's 13F filing for Q1 2015, filed 15 May 2015.